K
Kenneth J. Warrington
Researcher at Mayo Clinic
Publications - 267
Citations - 8685
Kenneth J. Warrington is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Giant cell arteritis & Vasculitis. The author has an hindex of 44, co-authored 212 publications receiving 6675 citations. Previous affiliations of Kenneth J. Warrington include University of Rochester & University of Turin.
Papers
More filters
Journal ArticleDOI
The Lifetime Risk of Adult-Onset Rheumatoid Arthritis and Other Inflammatory Autoimmune Rheumatic Diseases
Cynthia S. Crowson,Eric L. Matteson,Elena Myasoedova,Clement J. Michet,Floranne C. Ernste,Kenneth J. Warrington,John M. Davis,Gene G. Hunder,Terry M. Therneau,Sherine E. Gabriel +9 more
TL;DR: One in 12 women and 1 in 20 men will develop an inflammatory autoimmune rheumatic disease during their lifetime, which can serve as useful guides in counseling patients regarding their lifetime risk of these conditions and have important implications regarding disease awareness campaigns.
Journal ArticleDOI
T-Cell–Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes
Takako Nakajima,Stephanie Schulte,Kenneth J. Warrington,Stephen L. Kopecky,Robert L. Frye,Jörg J. Goronzy,Cornelia M. Weyand +6 more
TL;DR: It is proposed that T-cell–mediated endothelial cell injury is a novel pathway of tissue damage that contributes to plaque destabilization and the sensitizing effect of CRP suggests synergy between dysregulated T- cell function and acute phase proteins in acute coronary syndromes.
Journal ArticleDOI
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.
Carol A. Langford,David Cuthbertson,Steven R. Ytterberg,Nader Khalidi,Paul A. Monach,Simon Carette,Philip Seo,Larry W. Moreland,Michael H. Weisman,Curry L. Koening,Antoine G. Sreih,Robert Spiera,Carol A. McAlear,Kenneth J. Warrington,Christian Pagnoux,Kathleen M. McKinnon,Lindsy J. Forbess,Gary S. Hoffman,Renee Borchin,Jeffrey P. Krischer,Peter A. Merkel,Rula A. Hajj-Ali,Katherine Tuthill,Kathleen Gartner,Leah Madden,Brian Rice,Eric L. Matteson,Tanaz A. Kermani,Jane Jaquith,Naomi A. Amudala,Manuella Clark-Cotton,Sandra Messier,Julia Farquharson,Samyukta Jagadeesh,Dawn McBride,Swamy Venuturupalli,Daniel J. Wallace,Richard Phan,Nadia Verde,Denise Salinas,Jennifer Godina,Morgana L. Davids,Uzunma Udeh,Lourdes P. Sejismundo,Jennifer Harris +44 more
TL;DR: To compare the efficacy of abatacept to that of placebo for the treatment of giant cell arteritis (GCA) with a dummy pill, the objective is to establish an apples-to- apples comparison between the two treatments.
Journal ArticleDOI
Large-vessel giant cell arteritis: a cohort study
Francesco Muratore,Tanaz A. Kermani,Cynthia S. Crowson,Abigail B. Green,Carlo Salvarani,Eric L. Matteson,Kenneth J. Warrington +6 more
TL;DR: Although patients with large-vessel GCA had a lower rate of vision loss, they had a higher relapse rate and greater CS requirements, and the ACR criteria for GCA are inadequate for the classification of patients with LV-GCA.
Journal ArticleDOI
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.
Tanaz A. Kermani,Kenneth J. Warrington,Cynthia S. Crowson,Steven R. Ytterberg,Gene G. Hunder,Sherine E. Gabriel,Eric L. Matteson +6 more
TL;DR: Vigilance and screening for aortic aneurysms should be considered in all patients 5 years after the incidence of giant cell arteritis, as aortics manifestations were associated with increased mortality in GCA.